FDA approves second PARP inhibitor for germline BRCA-mutated Locally Advanced or...

Today, the FDA approvedĀ approved talazoparib (Talzenna), a drug of the PARP inhibitor class for breast cancer patients who possess harmful (or suspected harmful) BRCA2...

Triple Negative Breast Cancer Day is on March 8

March 3, 2018 is Triple-Negative Breast Cancer Day. We have known for a while that not all breast cancer is created equal. Most breast...

October is Breast Cancer Awareness month. This week is HBOC Week...

October is Breast Cancer Awareness Month. This week is National Hereditary Breast and Ovarian Cancer (HBOC) Week and Wednesday October 3, 2018 is Previvor...

FDA warns women about the risks of textured breast implants in...

The FDA released a statement from Binita Ashar, M.D., a general surgeon and the director of the Division of Surgical Devices in...

What is Breast Cancer?

Below is a brief summary on breast cancer terms including major types of breast cancer, breast cancer stage and grade, and the significance of...

Using Circulating Tumor DNA to Predict Cancer Recurrence and Guide Therapy

A recent technology is being increasingly used (at least in a research setting) to detect recurrence of cancer. The technology analyzes blood samples for...
0FansLike
74FollowersFollow
163FollowersFollow

Recent Posts

Ask a Breast Question
Ask a Breast Question X